摘要
洛铂是第3代新的铂类抗肿瘤药物,已获国家SFDA批准上市用于治疗晚期乳腺癌、小细胞肺癌和慢性粒细胞白血病。为了进一步提高临床医师对于洛铂的认识和重视,本文就近年来基础和临床研究新的重要文献作一综述。
As the third generation platinum drug, lobaplatin has been approved by SFDA in the treatment of advanced breast cancer, small-cell lung cancer and chronic granulocytic leukemia. To enhance the recognition of lobaplatin, the article briefly reviews the new progression of basic and clinical study literatures.
出处
《临床肿瘤学杂志》
CAS
2009年第12期1134-1139,共6页
Chinese Clinical Oncology
基金
国家"863"计划重点课题资助项目(2006AA020608)
关键词
洛铂
进展
Lobaplatin
Progression
